Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular membranes in coccidian parasites include multiple distinct structures such as the plasma membrane, the inner membrane complex (IMC), and the oocyst wall. The oocyst wall is a bilayered proteinaceous barrier formed during sexual development via secretion of wall forming body proteins and crosslinking by peroxidases, giving it exceptional environmental resilience. The IMC beneath the plasma membrane helps maintain parasite shape and motility. While these membrane structures are integral to pathogenicity and transmission, they are not single therapeutic targets but represent composite features of coccidian cell biology. Some oocyst wall proteins (e.g. EmGam56, EmGam82) may represent putative drug targets if inhibitors for associated enzymes (proteases, peroxidases) can be developed[1][6].
Disruption of oocyst wall formation (hypothetical: inhibition of proteases or peroxidases involved in oocyst wall protein crosslinking) General antiparasitic agents may interact with parasite membranes indirectly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular membrane structures of coccidian parasites.